| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Amir Minerbi, Winfried Häuser, Mary-Ann Fitzcharle. Medical Cannabis for Older Patients. Drugs & aging. vol 36. issue 1. 2019-02-12. PMID:30488174. |
this review provides a summary of the evidence for use of cannabinoids, and medical cannabis in particular, for this age group, with attention to efficacy and harms. |
2019-02-12 |
2023-08-13 |
human |
| Marco Colizzi, Sagnik Bhattacharyy. Cannabis use and the development of tolerance: a systematic review of human evidence. Neuroscience and biobehavioral reviews. vol 93. 2019-02-11. PMID:30056176. |
here we systematically review all studies examining the effects of single or repeated cannabinoid administration in man as a function of previous cannabis exposure. |
2019-02-11 |
2023-08-13 |
human |
| Marco Colizzi, Sagnik Bhattacharyy. Cannabis use and the development of tolerance: a systematic review of human evidence. Neuroscience and biobehavioral reviews. vol 93. 2019-02-11. PMID:30056176. |
research evidence tends to suggest that the acute effects of single cannabinoid administration are less prominent in regular cannabis users compared to non-regular users. |
2019-02-11 |
2023-08-13 |
human |
| Fabiana Piscitelli, Ester Pagano, Anna Lauritano, Angelo A Izzo, Vincenzo Di Marz. Development of a Rapid LC-MS/MS Method for the Quantification of Cannabidiol, Cannabidivarin, Δ Analytical chemistry. vol 89. issue 8. 2019-02-07. PMID:28343385. |
development of a rapid lc-ms/ms method for the quantification of cannabidiol, cannabidivarin, Δ cannabis has been known as a medicine for several thousand years across many cultures and its beneficial effects are mostly due to the presence of cannabinoids, unique natural products, whose pharmacology is going to gain increasing interest in the scientific community. |
2019-02-07 |
2023-08-13 |
Not clear |
| Federica Pollastro, Alberto Minassi, Luigia Grazia Fres. Cannabis Phenolics and their Bioactivities. Current medicinal chemistry. vol 25. issue 10. 2019-02-06. PMID:28799497. |
although cannabis sativa l. is one of the most versatile plant species with multipurpose use both as medical, alimentary source and as psychoactive abuse, its biomedical relevance focused the attention on major cannabinoids. |
2019-02-06 |
2023-08-13 |
Not clear |
| Arnau Busquets-Garcia, Maria Gomis-González, Victòria Salgado-Mendialdúa, Lorena Galera-López, Emma Puighermanal, Elena Martín-García, Rafael Maldonado, Andrés Ozait. Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 43. issue 5. 2019-02-06. PMID:28816239. |
cannabis affects cognitive performance through the activation of the endocannabinoid system, and the molecular mechanisms involved in this process are poorly understood. |
2019-02-06 |
2023-08-13 |
mouse |
| Manoela V Fogaça, Alline C Campos, Ludmila D Coelho, Ronald S Duman, Francisco S Guimarãe. The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling. Neuropharmacology. vol 135. 2019-02-04. PMID:29510186. |
the anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling. |
2019-02-04 |
2023-08-13 |
mouse |
| Elizabeth Robinson, Emily Murphy, Adam Friedma. Knowledge, Attitudes, and Perceptions of Cannabinoids in the Dermatology Community Journal of drugs in dermatology : JDD. vol 17. issue 12. 2019-02-04. PMID:30586258. |
64% of respondents did not know that cannabidiol is not psychoactive and 29% did not know that tetrahydrocannabinol is psychoactive.limitations: limited survey population.conclusions: dermatology providers are interested in prescribing cannabinoids and patients are speaking about cannabinoids with their dermatologists. |
2019-02-04 |
2023-08-13 |
human |
| Jenny L Wiley, R Allen Owens, Aron H Lichtma. Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids. Current topics in behavioral neurosciences. vol 39. 2019-01-31. PMID:27278640. |
psychoactive cannabinoids from the marijuana plant (phytocannabinoids), from the body (endocannabinoids), and from the research lab (synthetic cannabinoids) produce their discriminative stimulus effects by stimulation of cb |
2019-01-31 |
2023-08-13 |
Not clear |
| Barbara L F Kapla. Evaluation of Marijuana Compounds on Neuroimmune Endpoints in Experimental Autoimmune Encephalomyelitis. Current protocols in toxicology. vol 75. 2019-01-28. PMID:29512125. |
cannabinoid compounds refer to a group of more than 60 plant-derived compounds in cannabis sativa, more commonly known as marijuana. |
2019-01-28 |
2023-08-13 |
Not clear |
| Barbara L F Kapla. Evaluation of Marijuana Compounds on Neuroimmune Endpoints in Experimental Autoimmune Encephalomyelitis. Current protocols in toxicology. vol 75. 2019-01-28. PMID:29512125. |
exposure to marijuana and cannabinoid compounds has been increasing due to increased societal acceptance for both recreational and possible medical use. |
2019-01-28 |
2023-08-13 |
Not clear |
| Hemant Goyal, M Rubayat Rahman, Abhilash Perisetti, Nihar Shah, Rajiv Chhabr. Cannabis in liver disorders: a friend or a foe? European journal of gastroenterology & hepatology. vol 30. issue 11. 2019-01-28. PMID:30169449. |
the recent legalization of recreational marijuana use in some parts of the world, the discovery of new indications for the clinical application of cannabis, and the acceptance of the use of cannabis in practice has been paralleled by extensive research on the active components of cannabis and the endocannabinoid system within the human body. |
2019-01-28 |
2023-08-13 |
human |
| Hemant Goyal, M Rubayat Rahman, Abhilash Perisetti, Nihar Shah, Rajiv Chhabr. Cannabis in liver disorders: a friend or a foe? European journal of gastroenterology & hepatology. vol 30. issue 11. 2019-01-28. PMID:30169449. |
all in all, the recent trends in research, clinical experiences, as well as the legislature, has opened up new avenues towards the widespread clinical application of cannabis and its derivatives as well as modifiers of the components of the endocannabinoid system. |
2019-01-28 |
2023-08-13 |
human |
| Tina Mainka, Jan Stork, Ute Hidding, Carsten Buhman. [Cannabis in Parkinson's Disease: Hype or help?] Fortschritte der Neurologie-Psychiatrie. vol 86. issue 2. 2019-01-25. PMID:29325182. |
cannabis buds and extracts as well as synthetic cannabinoids have been available on prescription to patients with severe diseases since march 2017, with the costs covered by health insurance companies.the prescription of medical marihuana is not restricted to specific symptoms and is therefore also valid for patients with parkinson's disease. |
2019-01-25 |
2023-08-13 |
Not clear |
| Tina Mainka, Jan Stork, Ute Hidding, Carsten Buhman. [Cannabis in Parkinson's Disease: Hype or help?] Fortschritte der Neurologie-Psychiatrie. vol 86. issue 2. 2019-01-25. PMID:29325182. |
additionally, this article presents practical recommendations for the prescription of cannabinoids and patient counseling, e. g., on the effects of medical marijuana on driving capacity. |
2019-01-25 |
2023-08-13 |
Not clear |
| Mahra Nourbakhsh, Angela Miller, Jeff Gofton, Graham Jones, Bamidele Adeagb. Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases. Journal of forensic sciences. vol 64. issue 1. 2019-01-25. PMID:29768651. |
cannabinoid hyperemesis syndrome (chs) is one of the more clinically challenging effects of cannabis consumption. |
2019-01-25 |
2023-08-13 |
Not clear |
| Mary K Schwerdt, James R Gil. The pitfalls of per se thresholds in accurately identifying acute cannabis intoxication at autopsy. Forensic science, medicine, and pathology. vol 14. issue 4. 2019-01-25. PMID:30132114. |
this study examined decedents in whom quantified cannabis metabolites were detected in connecticut medical examiner autopsy samples, in which the medically-confined survival interval was longer (4-12 and > 12 h) than the expected duration of cannabinoid impairment effects. |
2019-01-25 |
2023-08-13 |
Not clear |
| Michael B Gatch, Michael J Forste. Δ Psychopharmacology. vol 235. issue 3. 2019-01-22. PMID:29138877. |
Δ novel synthetic cannabinoid compounds continue to appear in the market advertised as legal alternatives to marijuana and the older synthetic cannabinoid compounds which are now controlled substances. |
2019-01-22 |
2023-08-13 |
Not clear |
| Richard D Richins, Laura Rodriguez-Uribe, Kiah Lowe, Rebekah Ferral, Mary A O'Connel. Accumulation of bioactive metabolites in cultivated medical Cannabis. PloS one. vol 13. issue 7. 2019-01-22. PMID:30036388. |
inclusion of terpenoids with cannabinoids in the analysis of medical cannabis should be encouraged, as both of these classes of compounds could play a role in the beneficial medical effects of different cannabis strains. |
2019-01-22 |
2023-08-13 |
Not clear |
| b' Esther Papaseit, Clara P\\xc3\\xa9rez-Ma\\xc3\\xb1\\xc3\\xa1, Ana Pilar P\\xc3\\xa9rez-Acevedo, Olga Hladun, M Carmen Torres-Moreno, Robert Muga, Marta Torrens, Mag\\xc3\\xad Farr\\xc3\\xa. Cannabinoids: from pot to lab. International journal of medical sciences. vol 15. issue 12. 2019-01-14. PMID:30275754.' |
in recent years, the line between the natural (cannabis) and the synthetic (synthetic cannabinoids), the recreational (cannabis) and the medical (pharmaceutical cannabinoids and medical cannabis) has been crossed. |
2019-01-14 |
2023-08-13 |
Not clear |